Cite
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials.
MLA
Rehman, M. B., et al. “Efficacy and Safety of DPP-4 Inhibitors in Patients with Type 2 Diabetes: Meta-Analysis of Placebo-Controlled Randomized Clinical Trials.” Diabetes & Metabolism, vol. 43, no. 1, Feb. 2017, pp. 48–58. EBSCOhost, https://doi.org/10.1016/j.diabet.2016.09.005.
APA
Rehman, M. B., Tudrej, B. V., Soustre, J., Buisson, M., Archambault, P., Pouchain, D., Vaillant-Roussel, H., Gueyffier, F., Faillie, J.-L., Perault-Pochat, M.-C., Cornu, C., & Boussageon, R. (2017). Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials. Diabetes & Metabolism, 43(1), 48–58. https://doi.org/10.1016/j.diabet.2016.09.005
Chicago
Rehman, M B, B V Tudrej, J Soustre, M Buisson, P Archambault, D Pouchain, H Vaillant-Roussel, et al. 2017. “Efficacy and Safety of DPP-4 Inhibitors in Patients with Type 2 Diabetes: Meta-Analysis of Placebo-Controlled Randomized Clinical Trials.” Diabetes & Metabolism 43 (1): 48–58. doi:10.1016/j.diabet.2016.09.005.